文献速递母胎医学产科

长期吲哚美辛治疗在双胎输血综合征胎儿镜激光术后延长妊娠的疗效:一项协作队列研究

Efficacy of long-term indomethacin therapy in prolonging pregnancy after fetoscopic laser surgery for twin-to-twin transfusion syndrome: a collaborative cohort study.
PubMed 文献 · BJOG · 2021-12-01

这项回顾性队列研究纳入411例接受胎儿镜激光手术的双胎输血综合征妊娠,其中180例(43.8%)术后接受长期吲哚美辛治疗(至少48小时)。长期吲哚美辛组分娩中位孕周为33.6周,显著高于非长期组的31.1周(P < 0.001),且34、32、28、26周前早产风险均显著降低。

要点

  • 长期吲哚美辛组分娩中位孕周33.6周,非长期组31.1周,差异显著(P < 0.001)。
  • 长期吲哚美辛组34、32、28、26周前早产相对风险分别为0.69、0.51、0.37、0.18。
  • 预防一例32周前早产需治疗4例,预防一例34周前早产需治疗5例。

核心结论

  • 胎儿镜激光术后长期使用吲哚美辛与妊娠延长和早产风险降低相关,尤其对极早产。

研究设计与样本

  • 回顾性队列研究,采用前瞻性收集的数据,协作多中心设计。
  • 共557例连续的双胎输血综合征病例接受胎儿镜激光手术,最终纳入411例妊娠进行分析。

主要发现

  • 180例(43.8%)术后接受长期吲哚美辛治疗,231例(56.2%)未接受。
  • 两组胎儿干预时中位孕周均为20.4周,无差异。
  • 长期吲哚美辛组分娩中位孕周33.6周,非长期组31.1周,差异显著(P < 0.001)。
  • 长期吲哚美辛组胎儿镜激光手术至分娩间隔显著更长(P < 0.001)。
  • 长期吲哚美辛组34、32、28、26周前早产相对风险分别为0.69、0.51、0.37、0.18,均显著低于非长期组。

关键数值与推荐

  • 长期吲哚美辛治疗定义为使用吲哚美辛至少48小时。
  • 预防一例32周前早产需治疗4例,预防一例34周前早产需治疗5例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy of long-term indomethacin therapy (LIT) in prolonging pregnancy and reducing spontaneous preterm birth (PTB) in patients undergoing fetoscopic laser surgery (FLS) for the management of twin-to-twin transfusion syndrome (TTTS). DESIGN: Retrospective cohort study of prospectively collected data. SETTING: Collaborative multicentre study. POPULATION: Five hundred and fifty-seven consecutive TTTS cases that underwent FLS. METHODS: Long-term indomethacin therapy was defined as indomethacin use for at least 48 hours. Log-binomial regression was used to estimate the relative risk of PTB in the LIT group compared with a non-LIT group. Cox regression was used to evaluate the association between LIT use and FLS-to-delivery survival. MAIN OUTCOME MEASURES: Gestational age (GA) at delivery. RESULTS: Among the 411 pregnancies included, a total of 180 patients (43.8%) received LIT after FLS and 231 patients (56.2%) did not. Median GA at fetal intervention did not differ between groups (20.4 weeks). Median GA at delivery was significantly higher in the LIT group (33.6 weeks) compared with the non-LIT group (31.1 weeks; P < 0.001). FLS-to-delivery interval was significantly longer in the LIT group (P < 0.001). The risks of PTB before 34, 32, 28 and 26 weeks of gestation were all significantly lower in the LIT group compared with the non-LIT group (relative risks 0.69, 0.51, 0.37 and 0.18, respectively). The number needed to treat with LIT to prevent one PTB before 32 weeks of gestation was four, and to prevent one PTB before 34 weeks was five. CONCLUSION: Long-term indomethacin after FLS for TTTS was found to be associated with prolongation of pregnancy and reduced risk for PTB. TWEETABLE ABSTRACT: Long-term indomethacin used after fetoscopic laser surgery for twin-to-twin transfusion syndrome is effective in prolonging pregnancy and reducing the risk for preterm birth; especially extreme preterm birth.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Mustafa HJ, Krispin E, Tadbiri H, et al. Efficacy of long-term indomethacin therapy in prolonging pregnancy after fetoscopic laser surgery for twin-to-twin transfusion syndrome: a collaborative cohort study. BJOG. 2021. PMID: 34780110. doi:10.1111/1471-0528.17017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。